Merck Retained Earnings (Accumulated Deficit) 2010-2025 | MRK

Merck retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $66.097B, a 16.58% increase year-over-year.

  • Merck retained earnings (accumulated deficit) for 2024 were $63.069B, a 17.02% increase from 2023.
  • Merck retained earnings (accumulated deficit) for 2023 were $53.895B, a 11.76% decline from 2022.
  • Merck retained earnings (accumulated deficit) for 2022 were $61.081B, a 13.75% increase from 2021.

Merck Retained Earnings (Accumulated Deficit) 2010-2025 | MRK

  • Merck retained earnings (accumulated deficit) for 2024 were $63.069B, a 17.02% increase from 2023.
  • Merck retained earnings (accumulated deficit) for 2023 were $53.895B, a 11.76% decline from 2022.
  • Merck retained earnings (accumulated deficit) for 2022 were $61.081B, a 13.75% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$751.6B
Johnson & Johnson (JNJ)$377.5B
AbbVie (ABBV)$339.9B
Novo Nordisk (NVO)$307.8B
Roche Holding AG (RHHBY)$258.2B
Novartis AG (NVS)$255.6B
Pfizer (PFE)$145.8B
Sanofi (SNY)$119.2B
Bayer (BAYRY)$31.4B
Innoviva (INVA)$1.2B